Reading HCTI? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HCTI free→Reading HCTI? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HCTI free→QuarterlyIQ Insights · HCTI
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Entry into a Material Definitive Agreement. Private Placement of Original Issue Discount Senior Convertible Promissory Notes On June 12, 2026, Healthcare Triangle, Inc. (the “Company”) completed a private placement offering (the “Note Offering”) of its 15% original issue discount senior convertible promissory notes (the “Notes”) in the aggregate principal amount of $4.235 million for aggregate gross proceeds of approximately $3.6 million, before deducting placement agent fees and other relate…
The Notes, the shares issuable upon conversion of the Notes, the Warrant and the shares issuable upon exercise of the Warrant have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and were offered and sold, or will be issued, in reliance upon exemptions from the registration requirements of the Securities Act, including Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder, and appli…
Regulation FD Disclosure. On June 12, 2026, the Company issued a press release announcing the closing of the Note Offering. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by referen…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under
Entry into a Material Definitive Agreement. On April 7, 2026, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”), entered into a Platform Development Agreement (the “ Agreement ”) with SecureKloud Technologies Limited, an Indian corporation (“ SKL ”), as lead contractor, and Blockedge Technologies Inc., a subsidiary of SKL (“ Blockedge ”), as sub-contractor. The Agreement is made effective as of March 31, 2026. The Agreement supplements and amends the Company’s master service…
Other Events. On March 11, 2026, Healthcare Triangle, Inc. (the “Company”) issued a press release announcing that the Board of Directors of the Company had approved a share repurchase program under which the Company may repurchase up to $2,000,000 of its outstanding shares of common stock on the open market, in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The Company’s decision to repurchase its share…
Entry Into Material Definitive Agreement. On February 26, 2026, Healthcare Triangle, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell to the Purchasers in a registered direct offering (A) an aggregate of 421,553 shares (the “Shares”) of common stock, par value $0.00001 per share (the “Common Stock”), of the Company, at an offering price of…
Material Modification to Rights of Security Holders. To the extent required by
Entry into a Material Definitive Agreement. On January 22, 2026, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”), entered into a Share Purchase Agreement (the “ Share Purchase Agreement ”), by and among (i) Teyame AI Holdings Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Buyer ”), (ii) the Company, (iii) Teyame AI LLC, a St Kitts and Nevis corporation (the “ Intermediary Seller ”), (iv) CH 109, S.L., a company incorporated in Spain (“ CH 109 ”)…
Completion of Acquisition or Disposition of Assets. The information set forth under
Unregistered Sales of Equity Securities. In connection with the transactions described under Items 1.01 and 2.01 of this Current Report on Form 8-K, the Company issued restricted shares of its common stock and a series of its preferred stock that is convertible into shares of the Company’s common stock (and, in certain circumstances, a pre-funded warrant to acquire shares of the Company’s common stock), as contemplated by the Share Purchase Agreement. The securities issued in connection with…
Submission of Matters to a Vote of Security Holders. On December 5, 2025, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”) entered into a non-binding advance agreement (the “ Advance Agreement ”) with Teyame A.I. LLC, a St. Kitts and Nevis limited liability company (“ Teyame ”), in connection with a proposed acquisition by the Company of 100% of the equity interests of Teyame 360 S.L. and Datono Mediacion S.L., each a company incorporated in Spain (collectively, the “ Targe…
Entry into a Material Definitive Agreement. On November 20, 2025, Healthcare Triangle, Inc., a Delaware corporation, (the “Company”), entered into a Securities Purchase Agreement (“Purchase Agreement”) with certain institutional investors (the “Investors”). Under the Purchase Agreement, the Company has agreed to issue 20% original issue discount senior unsecured convertible promissory notes (“Notes”) in an aggregate original principal amount of up to $15,000,000, which will be convertible int…
Unregistered Sales of Equity Securities. The issuance and sale of the Notes and the issuance of the conversion shares upon conversion of the Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and will be made in reliance on the private offering exemption provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D promulgated thereunder. The Investor represented to the Company that it is an “accredited investor” as defined…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under
Entry into a Material Definitive Agreement. On November 18, 2025, Healthcare Triangle, Inc., a Delaware corporation, (the “Company”), entered into a Sales Agreement (the “Agreement”) with Spartan Capital Securities, LLC (“Spartan”), as sales agent providing for the sale by the Company of shares of its common stock, par value $0.00001 per share (the “Common Stock”), from time to time, in an “at the market offering” program through Spartan with certain limitations on the amount of Common Stock…
Entry into a Material Definitive Agreement. On October 2, 2025, Healthcare Triangle, Inc. (the “Company”) entered into a warrant inducement letter (the “Inducement Agreement”) with certain holders (the “Holders”) of the Company’s warrants to purchase shares of the Company’s common stock, par value $0.00001 per share (the “Common Stock”), issued in a private placement offering that closed on February 28, 2025 (the “Existing Warrants”). Pursuant to the Inducement Agreement, the Holders of the E…
Material Modification to Rights of Security Holders. To the extent required by
The New Warrants, the New Warrant Shares, the Advisor Warrants and the Advisor Warrant Shares are being issued in a private placement transaction and have not been registered under the Securities Act and may not be sold in the United States absent registration or an applicable exemption from the registration requirements.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. NASDAQ Notice Regaining Compliance; No Further Action Required On September 15, 2025, Healthcare Triangle, Inc. (the “Company”) received a letter from the Nasdaq Stock Market (“Nasdaq”) indicating that the Company had previously failed to comply with Nasdaq Listing Rule 5635(a)(1), which requires shareholder approval prior to the issuance of common stock representing 20% or more of the pre-tra…
Entry into a Material Definitive Agreement. On August 28, 2025, the Company and Niyama Healthcare, Inc. entered into Amendment No. 1 to their Asset Transfer Agreement dated June 16, 2025. Amendment No. 1 replaces Clause (ii) of Section 1(b) of the Agreement to provide that the Seller will receive 1,388,041 restricted shares of the Company’s common stock, issuable on the effective date after receiving approval of such issuance by a majority of the voting power of the Company’s voting stock. Th…
Material Modification to Rights of Security Holders. To the extent required by
of this Current Report on Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such a filing.. Forward-Looking Statem…
Completion of Acquisition or Disposition of Assets. The information set forth under
Entry into a Material Definitive Agreement. On June 16, 2025, Healthcare Triangle, Inc. (the “Company”) and Niyama Healthcare, Inc., a Delaware corporation, a provider of Mental Health and Hospital Information Systems technology, across India, South East Asia, and Europe (the “Seller”) entered into an Asset Transfer Agreement (the “Agreement”). Pursuant to the Agreement, the Company agreed to purchase from the Seller the Transferred Assets (as defined below), and (ii) the Seller’s 100% shareh…
Importance-ranked changes since the prior daily snapshot.
Management fell by 14.7 points (from 56.3 to 41.6).
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.